PATHOLOGICAL EVOLUTION AND INTERNAL MEDICINE MANAGEMENT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE ERA OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)